Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge (Q40508538)

21 September 2017

title

Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge (English)

1 reference

21 September 2017

0 references

0 references

Karaca K

1

1 reference

21 September 2017

Bowen R

2

1 reference

21 September 2017

Austgen LE

3

1 reference

21 September 2017

Teehee M

4

1 reference

21 September 2017

Siger L

5

1 reference

21 September 2017

Grosenbaugh D

6

1 reference

21 September 2017

Loosemore L

7

1 reference

21 September 2017

Audonnet JC

8

1 reference

21 September 2017

Nordgren R

9

1 reference

21 September 2017

Minke JM

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

11 March 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

29

1 reference

21 September 2017

page(s)

3808-3813

1 reference

Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Exposure of Domestic Mammals to West Nile Virus during an Outbreak of Human Encephalitis, New York City, 1999

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Serological, reverse transcriptase-polymerase chain reaction, and immunohistochemical detection of West Nile virus in a clinically affected dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

West Nile virus encephalitis and myocarditis in wolf and dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Experimental infection of cats and dogs with West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Experimental infection of horses with West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

CD8 T cells mediate recovery and immunopathology in West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

Immunization of mice against West Nile virus with recombinant envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

West Nile viral encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.02.020

10.1016/J.VACCINE.2005.02.020

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference